Format

Send to

Choose Destination
See comment in PubMed Commons below
Cell Mol Life Sci. 2014 Mar;71(5):793-811. doi: 10.1007/s00018-013-1380-7. Epub 2013 Jun 11.

The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Author information

1
Institut Pasteur de Montevideo, Calle Mataojo 2020, CP 11400, Montevideo, Uruguay, spantano@pasteur.edu.uy.

Abstract

The high toxicity of the seven serotypes of botulinum neurotoxins (BoNT/A to G), together with their specificity and reversibility, includes them in the list A of potential bioterrorism weapons and, at the same time, among the therapeutics of choice for a variety of human syndromes. They invade nerve terminals and cleave specifically the three proteins which form the heterotrimeric SNAP REceptors (SNARE) complex that mediates neurotransmitter release. The BoNT-induced cleavage of the SNARE proteins explains by itself the paralysing activity of the BoNTs because the truncated proteins cannot form the SNARE complex. However, in the case of BoNT/A, the most widely used toxin in therapy, additional factors come into play as it only removes a few residues from the synaptosomal associate protein of 25 kDa C-terminus and this results in a long duration of action. To explain these facts and other experimental data, we present here a model for the assembly of the neuroexocytosis apparatus in which Synaptotagmin and Complexin first assist the zippering of the SNARE complex, and then stabilize and clamp an octameric radial assembly of the SNARE complexes.

PMID:
23749048
DOI:
10.1007/s00018-013-1380-7
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center